Connect with us

Technology

GSK Leverages Genedata Biologics as End-to-End Automation and Data Science Platform

Published

on

Global biopharma leader drives digital innovation, data sciences, and next-generation automation approaches with Genedata’s cloud-based Biopharma Platform

BASEL, Switzerland, July 31, 2024 /PRNewswire-PRWeb/ — Genedata, a leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that GSK, a leading biopharma company, has extended the use of Genedata Biologics® to new application areas in data sciences, analytics, and R&D automation.

Access to structured and organized data from Genedata Biologics enables our data science, predictive modelling, and AI/ML projects as we continue our work to optimize the clinical effectiveness of our medicines. Steve Martin, Ph.D., VP and Head of Large Molecule Discovery at GSK

“We’ve migrated our on-premise hosted version of Biologics to Genedata’s SaaS platform to leverage the various benefits that cloud-hosting offers. We continue to integrate data workflows for design, production, screening, characterization and engineering of novel biotherapeutics whilst developing features to handle bi- and multi-specific modalities,” said Steve Martin, Ph.D., VP and Head of Large Molecule Discovery. “At GSK we use leading edge data and platform technologies to discover and develop new medicines and vaccines better and faster to positively impact the health of people at scale. Access to structured and organized data from Genedata Biologics enables our data science, predictive modelling, and AI/ML projects as we continue our work to optimize the clinical effectiveness of our medicines.”

Since its initial deployment in 2013, Genedata Biologics has become a core part of GSK’s Large Molecule Discovery team’s antibody discovery data platform, automating lab operations and data streams from diverse discovery projects. Genedata Biologics directly integrates with GSK’s automation systems to generate, express, and purify large numbers of candidates, followed by high-throughput characterization and lead evaluation. Automated cloning and expression runs generate a substantial number of data and metadata points that Genedata Biologics can store and help cascade to downstream consumers across the organization.

The system offers real-time access to all critical data to GSK’s scientists, managers, and executives, which promotes synergies within and across projects. The Genedata platform also enables users across R&D to monitor program performance, resource and project planning, and task prioritization.

“We are pleased that GSK, one of the leading innovators in the development of novel biopharmaceuticals, has decided to expand the use of Genedata Biologics as their foundation platform for guided biotherapeutics discovery,” said Othmar Pfannes, Ph.D., CEO of Genedata. “Digital transformation is opening new horizons in biopharmaceutical R&D, and we are excited that our platform is helping GSK to develop innovative biotherapies faster.”

About Genedata
Genedata transforms data into intelligence with innovative software solutions that incorporate extensive biopharma R&D domain knowledge. Multinational biopharmaceutical organizations and cutting-edge biotechs around the globe rely on Genedata to digitalize and automate data-rich and complex R&D processes. From early discovery all the way to the clinic, Genedata solutions help maximize the ROI in R&D expenditure. Founded in 1997, Genedata is headquartered in Basel, Switzerland with additional offices in Boston, London, Munich, San Francisco, Singapore, and Tokyo.
http://www.genedata.com
LinkedIn | X | YouTube

Contact 
Allison Kurz
Genedata
Public Relations
pr@genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company’s products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Media Contact

Allison Kurz, Genedata, +41 61 511 84 00, pr@genedata.com, www.genedata.com

View original content to download multimedia:https://www.prweb.com/releases/gsk-leverages-genedata-biologics-as-end-to-end-automation-and-data-science-platform-302207516.html

SOURCE Genedata

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Nutex Health Data Breach: Edelson Lechtzin LLP Investigates Theft of Patient and Employee Data

Published

on

By

Free case evaluations for individuals affected by the Nutex Health cyberattack claimed by The Gentlemen ransomware group

HOUSTON, Sept. 1, 2026 /PRNewswire/ — Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a cyberattack on Nutex Health Inc. (NASDAQ: NUTX). In filings with the Securities and Exchange Commission, Nutex Health confirmed that an unauthorized party accessed and stole private and confidential data — and that the attacker threatened to publish it. Affected individuals may be entitled to compensation.

What Happened

Nutex Health, a Houston-based micro-hospital operator, first disclosed unauthorized network activity on August 24, 2026. On August 31, 2026, the company escalated its disclosure to a material cybersecurity incident, confirming that an unauthorized third party accessed and exfiltrated data from its servers and then threatened to post it externally.

The ransomware-as-a-service group known as The Gentlemen added Nutex Health to its leak site and claimed responsibility — the hallmark of a “double extortion” attack, in which criminals both steal data and threaten to publish it. Nutex Health’s hospital division operates 28 facilities across 12 states.

Information Exposed

According to Nutex Health’s SEC filings, the accessed and exfiltrated data is believed to include private and/or confidential:

Patient informationEmployee informationCredentialed provider informationBusiness and financial information

Because patient and health-related data may be involved, affected individuals face a heightened risk of both financial identity theft and medical identity theft.

Who May Be Affected

Patients, employees, and credentialed providers connected to Nutex Health may be at risk. The company has said it intends to notify those affected. A notification letter is the most reliable confirmation that your information was involved.

Litigation Already Underway

A proposed class action has already been filed against Nutex Health on behalf of individuals whose personal or protected health information was allegedly accessed. Edelson Lechtzin LLP is separately investigating claims and evaluating affected individuals’ rights at no cost.

What Affected Individuals Should Do

Place a credit freeze with all three bureaus — Equifax, Experian, and TransUnion. It is free and takes minutes.Set up fraud alerts and monitor your credit reports and account statements.Review medical bills and explanations of benefits for services you did not receive.Watch for phishing — breach notices are a common disguise. Do not click links in unexpected messages.Preserve any breach letters or emails you receive.

Free Case Evaluation

To request a free, confidential consultation, click HERE.

Speak with a data privacy attorney: Marc Edelson, Esq., Edelson Lechtzin LLP, 411 S. State Street, Suite N-300, Newtown, PA 18940 | Phone: 844-696-7492 | Email: medelson@edelson-law.com

About Edelson Lechtzin LLP

Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. The firm handles data breach, securities fraud, antitrust, ERISA, wage theft, and consumer fraud matters.

This press release may be considered Attorney Advertising in some jurisdictions.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nutex-health-data-breach-edelson-lechtzin-llp-investigates-theft-of-patient-and-employee-data-302867007.html

SOURCE Edelson Lechtzin LLP

Continue Reading

Technology

Maritime Launch Services and Isar Aerospace Extend Deadline to Finalize Statement of Work and Programmatic Milestones

Published

on

By

HALIFAX, NS and MUNICH, Sept. 1, 2026 /CNW/ — Maritime Launch Services Inc. (CBOE: MAXQ) (OTCQB: MAXQF) and Isar Aerospace have agreed to extend the deadline to provide additional time to complete the statement of work and certain programmatic milestones contemplated under their previously-announced facilities usage agreement for Spaceport Nova Scotia. The deadline was extended from September 1, 2026, to September 15, 2026.

The parties continue to make strong progress through an intensive and productive planning process. The extension reflects the time required to complete this work.

“We are very pleased with the progress being made between both parties,” said Stephen Matier, President and CEO of Maritime Launch Services. “Our teams are working through the detailed planning required to advance this important program. The additional 14 days will allow us to complete that work and maintain the strong momentum we have established together.”

The extension does not change the other key terms of the facilities usage agreement announced on July 7, 2026. The parties remain focused on advancing the development of Isar Aerospace’s dedicated launch complex for its Spectrum launch vehicle at Spaceport Nova Scotia, with first orbital launches targeted for 2028.The agreement supports the development of sovereign orbital launch capability from Canada and expands Isar Aerospace’s launch capability into North America.

“We are making strong progress together with Maritime Launch Services as we advance the detailed planning for our launch operations at Spaceport Nova Scotia,” said Alexandre Dalloneau, Vice President Mission and Launch Operations, Isar Aerospace. “The work between our teams has been intensive and productive, and this additional time will allow us to finalize the remaining details as we move toward execution of the program.”

About Maritime Launch Services 
Maritime Launch Services Inc. (CBOE: MAXQ, OTCQB: MAXQF) is a Canadian-owned commercial space company based in Nova Scotia. Maritime Launch is developing Spaceport Nova Scotia, a dual-use commercial spaceport designed to support both civil and defence-related space missions. The spaceport will provide satellite launch services to domestic and international clients across the global commercial space market, supporting a wide range of orbital inclinations from a single location.

Spaceport Nova Scotia is Canada’s first commercial orbital launch complex, enabling small and medium launch vehicles to place satellites into low Earth orbit.

For more information, visit: www.maritimelaunch.com

About Isar Aerospace

The European space company Isar Aerospace offers launch services for transporting small and medium-sized satellites and satellite constellations into Earth orbit. The launch vehicles used to transport these satellites are developed, manufactured, and tested almost entirely in-house. Headquartered near Munich, Germany, Isar Aerospace was founded in 2018 and has grown to over 400 employees, working across 5 international locations. Private funding from international investors provides strong backing for the company’s pioneering approach to scale and industrialize launch vehicle production through vertical integration. More information: www.isaraerospace.com

https://x.com/maritimelaunch

https://www.linkedin.com/company/maritimelaunch

Forward-Looking Statements

This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. The forward-looking statements included in this press release include (without limitation) statements regarding the continuing of the term of the facilities usage agreement, continuing negotiations of the parties to the facilities usage agreement and the timing of completion of such negotiations, and anticipated launch timing.

Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Although Maritime Launch has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be factors that cause results not to be as anticipated, estimated or intended. Such forward-looking statements are subject to risks, uncertainties and other factors which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statement. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Risks and uncertainties that may cause such differences include but are not limited to: risks related to Maritime Launch’s strategy going forward; capital requirements; risks related to interest rates and inflationary pressures on the cost of doing business; geopolitical events and changes, availability of third-party contractors and service providers, and other risks inherent in the industry in which Maritime Launch operates.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/maritime-launch-services-and-isar-aerospace-extend-deadline-to-finalize-statement-of-work-and-programmatic-milestones-302866904.html

SOURCE Maritime Launch Services Inc.

Continue Reading

Technology

Visa Launches Enhanced A2A Protect Innovations to Help Financial Institutions Stop Fraud Before Money Leaves Accounts

Published

on

By

New unified fraud score is the company’s first combined offering in-market since Visa’s acquisition of Featurespace which delivers real-time A2A risk insightsNew graph-powered, agentic capability helps accelerate complex fraud and risk investigationsA2A Protect has been shown to reduce over 50% more fraud and help reduce over 40% in unnecessary fraud alerts

SINGAPORE, Sept. 2, 2026 /PRNewswire/ — Visa (NYSE: V), a world leader in digital payments, today announced an enhanced version of A2A Protect, delivering real-time risk insights that help banks stop account-to-account fraud before money leaves customer accounts. The expanded solution introduces a new unified fraud score—Visa’s first in-market integration of Featurespace technology—giving financial institutions faster, clearer signals to detect more fraud while reducing unnecessary alerts.

In addition, Visa is developing its complementary fraud prevention capabilities through Visa Graph IQ, a graph-powered, agentic investigation capability that provides deeper investigative insights to help financial institutions uncover fraud networks, identify money mule activity, detect emerging threats, and accelerate fraud and risk investigations.

As account-to-account (A2A) payments accelerate globally, A2A transactions are projected to surpass 5.8 trillion by 2028, a 160% increase from 2024, with Asia Pacific expected to account for more than half of global A2A consumer transactions by 2028[1]. While this growth presents significant opportunities, it also creates new fraud risks. Asia Pacific accounts for an estimated 67% of the world’s USD 1.03 trillion in annual scam losses, with Asia alone recording USD 688.42 billion in scam-related losses in 2024[2]. This growing threat is driving increased regulatory and industry focus on strengthening fraud prevention capabilities and enhancing consumer protection.

A2A Protect leverages advanced AI and sophisticated transfer learning and gives banks immediate access to critical global risk insights on A2A transactions, without waiting months for models to develop intelligence from a bank’s own transaction data, and without having to wait for other banks to join a consortium, delivering results and value from day one. Banks that opt in can incorporate additional network-level signals to enhance detection of emerging threats operating across the ecosystem.

“As account-to-account payments continue to accelerate across Asia Pacific, financial institutions are looking for ways to grow digital payments with confidence while maintaining a seamless experience for consumers and businesses,” said Serene Gay, Head of Value-Added Services, Asia Pacific at Visa. “The latest enhancements to A2A Protect combine Visa’s network intelligence with advanced AI capabilities to help our clients detect fraud earlier, respond faster to emerging threats, and strengthen trust in the digital payments ecosystem.”

For financial institutions that opt into network level intelligence sharing, A2A Protect highlights emerging scam hotspots and coordinated fraud activity – insights that may be difficult for individual financial institutions to detect alone, and that help the wider ecosystem respond faster to new threats. This gives financial institutions an earlier and more complete view of risk, helping to identify scams before authorisation. In fact, Visa A2A Protect has been shown to increase fraud detection by up to 75% in the first six months of deployment.

A2A Protect integrates with financial institutions’ current systems through a single API, reducing implementation time and complexity. Each alert includes a plain language explanation of why a transaction was flagged, helping fraud teams act quickly and confidently without disrupting genuine customers.

For more information on how Visa works to prevent fraud across the ecosystem, visit Visa.com/security.

[1]  Juniper Research, Global Instant Payments Market Report, September 2025

[2] GASA, Asia Scam Report, 2024

About Visa Inc.
Visa (NYSE: V) is a world leader in digital payments, facilitating payments transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/visa-launches-enhanced-a2a-protect-innovations-to-help-financial-institutions-stop-fraud-before-money-leaves-accounts-302866292.html

SOURCE Visa

Continue Reading

Trending